I
Institute for Respiratory Health | Perth , Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Axatilimab
RSP-1502
Bisoprolol
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aerugin...
Enrolling
Cystic Fibrosis Lung
Pseudomonas Aeruginosa
Drug: Tobramycin inhalation solution
Drug: RSP-1502
The study will evaluate the efficacy and safety of axatilimab in participants with IPF.
Enrolling
Idiopathic Pulmonary Fibrosis
Drug: Axatilimab
Other: Placebo
Trial sponsors
R
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems